Quanterix Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, everybody. Welcome to Day 4 of the health care conference. I'm Tycho Peterson from the life science team. It's my pleasure to introduce our next company this morning, Quanterix.
Before I turn it over to Kevin, just a quick reminder. You can submit questions through the website.
And with that, let me turn it over to Kevin.
Thanks very much, Tycho. I think this is the 20th time I've presented at JPMorgan, and I would encourage investors to look at the regulatory filings. We will be making some forward-looking statements.
Now to start off in this conference, it's been incredible the number of meetings we've had over the last 4 days. And we've tried to incorporate some of the top questions that we were seeing from our investor base into this agenda.
But starting off with our achievements in 2021. We have this symbiotic relationship between RUO research and diagnostics that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |